|
| Exchange Disseminated Time 02/02/2017 12:27:51 | Kilitch Drugs India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 13, 2017, inter alia, to consider and take on record the following matters:
- Unaudited (Provisional) Financial Result for the quarter ended December 31, 2016 along with the Limited Review Report as submitted by the Statutory Auditors of the Company.
Closure of Trading window:
The Company will close the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 on February 02, 2017 and the trading window will open on February 16, 2017. |
|
|